Hindustan Unilever (HUL) is fully acquiring Zywie Ventures (OZiva), a key move in its Health & Wellbeing strategy.

HUL is paying Rs. 824 Cr for the remaining 49% stake, making OZiva a wholly-owned subsidiary.

This deepens HUL's presence in the fast-growing vitamins, minerals, and supplements market, leveraging HUL's ecosystem for further growth.

OZiva has shown impressive performance, scaling to approximately Rs. 480 Cr in 2025 with a 130% CAGR.

Additionally, HUL divested its 19.8% stake in Nutritionalab for Rs. 307 Cr, streamlining its portfolio.